Stock Analiz

Merck & Co., Inc. (MRK) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Merck & Co.’s revenue went from $39.8B in fiscal 2016 to $65.0B in fiscal 2025, growth of about 5.6% a year.

Net income in fiscal 2025 was $18.3B, a net margin of 28.1%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $67.4B and net income $2.5B.

Free cash flow was $12.4B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 10% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $39.8B162017: $40.1B172018: $42.3B182019: $39.1B192020: $41.5B202021: $48.7B212022: $59.3B222023: $60.1B232024: $64.2B242025: $65.0B25$65.0B
Net income
2016: $3.9B162017: $2.4B172018: $6.2B182019: $9.8B192020: $7.1B202021: $13.0B212022: $14.5B222023: $365M232024: $17.1B242025: $18.3B25$18.3B
Free cash flow
2016: $8.8B162017: $4.6B172018: $8.3B182019: $10.1B192020: $5.8B202021: $8.7B212022: $14.7B222023: $9.1B232024: $18.1B242025: $12.4B25$12.4B
EPS (diluted)
2016: $1.41162017: $0.87172018: $2.32182019: $3.81192020: $2.78202021: $5.14212022: $5.71222023: $0.14232024: $6.74242025: $7.2825$7.28

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$67.4B$65.0B$64.2B$60.1B$59.3B$48.7B$41.5B$39.1B$42.3B$40.1B$39.8B
Gross profit$48.3B$48.6B$49.0B$44.0B$41.9B$35.1B$27.9B$27.1B$28.8B$27.2B$25.8B
Operating income$6.7B$22.4B$21.2B$3.0B$17.4B$14.7B$6.7B$8.1B$9.5B$7.3B$5.4B
Net income$2.5B$18.3B$17.1B$365M$14.5B$13.0B$7.1B$9.8B$6.2B$2.4B$3.9B
EPS (diluted)$0.98$7.28$6.74$0.14$5.71$5.14$2.78$3.81$2.32$0.87$1.41
R&D$30.8B$15.8B$17.9B$30.5B$13.5B$12.2B$13.4B$9.7B$9.8B$10.3B$10.3B
Revenue growth—+1.3%+6.7%+1.4%+21.7%+17.3%+6.1%−7.5%+5.4%+0.8%+0.8%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$18.7B$16.5B$21.5B$13.0B$19.1B$13.1B$10.3B$13.4B$10.9B$6.5B$10.4B
Capital spending-$4.0B-$4.1B-$3.4B-$3.9B-$4.4B-$4.4B-$4.4B-$3.4B-$2.6B-$1.9B-$1.6B
Free cash flow$14.7B$12.4B$18.1B$9.1B$14.7B$8.7B$5.8B$10.1B$8.3B$4.6B$8.8B
Dividends paid$8.4B$8.2B$7.8B$7.4B$7.0B$6.6B$6.2B$5.7B$5.2B$5.2B$5.1B
Buybacks$3.5B$5.1B$1.3B$1.3B$0$840M$1.3B$4.8B$9.1B$4.0B$3.4B
Stock-based pay$1.1B$820M$761M$645M$541M$479M$441M$388M$348M$312M$300M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$14.6B$13.7B$7.1B$13.2B$8.1B$8.1B$10.4B$8.9B$8.5B$14.3B
Debt—$50.5B$38.3B$36.3B$32.0B$34.6B$33.4B$27.3B$25.1B$24.4B$24.6B
Equity—$52.6B$46.3B$37.6B$46.0B$38.2B$25.3B$25.9B$26.7B$34.3B$40.1B
Total assets—$136.9B$117.1B$106.7B$109.2B$105.7B$91.6B$84.4B$82.6B$87.9B$95.4B
Shares (diluted)2.48B2.51B2.54B2.55B2.54B2.54B2.54B2.58B2.68B2.75B2.79B

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin71.8%74.8%76.3%73.2%70.6%72.0%67.2%69.3%68.1%67.8%64.8%
Operating margin10.0%34.5%33.1%5.1%29.4%30.1%16.1%20.6%22.4%18.1%13.4%
Net margin3.6%28.1%26.7%0.6%24.5%26.8%17.0%25.2%14.7%6.0%9.8%
FCF margin21.9%19.0%28.2%15.2%24.8%17.8%14.0%25.7%19.6%11.4%22.0%
ROIC—18.9%21.6%3.2%19.7%18.0%8.8%11.8%13.0%9.8%7.0%
ROE—34.7%37.0%1.0%31.6%34.2%27.9%38.0%23.3%7.0%9.8%

Frequently asked questions

What is Merck & Co.’s annual revenue?

$65.0B in fiscal 2025 and $67.4B over the twelve months to September 30, 2026.

How much profit does Merck & Co. make?

Net income was $18.3B in fiscal 2025 (net margin 28.1%).

Is Merck & Co.’s revenue growing?

Yes: revenue rose 1.3% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.